Anesthetics, Inhalation
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
33%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Advancing Brain Outcomes in Pediatric Critically Ill Patients Sedated With Volatile AnEsthestic Agents
Oxygen Consumption and Sevoflurane Uptake Based on Physiological Dead Space Estimation
50% Effective Concentration of Sevoflurane for Immobility
Effect of Rocuronium and Sugammadex Under Sevoflurane and Desflurane Anesthesia in Children
Blood Levels of Sevoflurane and Desflurane
A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon